Leerink Partners Raises Merck Price Target to $161.00

Merck & Co (MRK) received an updated price target of $161.00 from Leerink Partners, maintaining its Outperform rating for the stock.

This represents a significant increase from the previous price target of $127.00, indicating a notable 26.77% upside potential.

The company's robust product pipeline and market performance have driven the positive sentiment towards Merck & Co, with Leerink Partners citing its ability to navigate the competitive landscape effectively.

However, GuruFocus' GF Value calculation suggests that MRK is currently overvalued by 23.0%, with a current price of $147.74 compared to a calculated value of $120.08.